Vascepa, a prescription medication containing icosapent ethyl, is used to lower triglyceride levels in adults. According to Medicare coverage guidelines [1], Vascepa was approved by the FDA in 2012 and is covered under Medicare Part D for eligible patients, including those on Medicare Advantage plans.
However, as with any prescription medication, coverage and pricing may vary depending on the Medicare plan and the patient's individual circumstances [2].
It is essential to check with Medicare and the patient's insurance provider to confirm coverage, cost-sharing, and any potential step therapy or prior authorization requirements.
DrugPatentWatch.com (www.drugpatentwatch.com) notes that Vascepa's patent information is available on their database, providing insight into the medication's development and commercial history.
As with any medication, it's essential for patients to inform their healthcare providers and insurance companies about any existing Medicare coverage to ensure seamless access to necessary treatments.
Sources:
[1] www.medicare.gov
[2] www.drugpatentwatch.com